Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.56 |
| ▸ | THRB | P10828 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | APEX1 | P27695 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.31 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.31 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.31 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.31 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.31 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.31 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.31 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.31 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.31 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.31 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL212008 | 0.92 | THRB (0.55) | TSHRTHRBALDH1A1TDP1POLB | |
| SCHEMBL671674 | 0.90 | THRB (0.53) | TSHRTHRBALDH1A1TDP1POLB | |
| SCHEMBL673043 | 0.90 | THRB (0.53) | TSHRTHRBALDH1A1TDP1POLB | |
| SCHEMBL670913 | 0.90 | THRB (0.53) | TSHRTHRBALDH1A1TDP1POLB | |
| SCHEMBL11420243 | 0.89 | TSHR (0.62) | TSHRTHRBALDH1A1TDP1POLB | |
| SCHEMBL21385092 | 0.87 | THRB (0.52) | TSHRTHRBALDH1A1TDP1POLB | |
| SCHEMBL10427136 | 0.86 | TSHR (0.53) | TSHRTHRBALDH1A1TDP1POLB | |
| SCHEMBL1695699 | 0.86 | THRB (0.55) | TSHRTHRBALDH1A1TDP1POLB | |
| SCHEMBL10427274 | 0.86 | THRB (0.55) | TSHRTHRBALDH1A1TDP1POLB | |
| SCHEMBL10427163 | 0.86 | TSHR (0.53) | TSHRTHRBALDH1A1TDP1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2485295-B1 | POROUS MEMBRANE FOR SECONDARY BATTERY, AND SECONDARY BATTERY | ZEON CORP (JP) | 2019-03-20 | — | — | EP | claimed |
| EP-2485295-B1 | POROUS MEMBRANE FOR SECONDARY BATTERY, AND SECONDARY BATTERY | ZEON CORP (JP) | 2019-03-20 | — | — | EP | disclosed |
| US-8329377-B2 | Imide compound and chemically amplified resist composition containing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-12-11 | — | — | US | disclosed |
| EP-2485295-A1 | POROUS MEMBRANE FOR SECONDARY BATTERY, AND SECONDARY BATTERY | Zeon Corporation (JP) | 2012-08-08 | — | — | EP | disclosed |
| US-20120189897-A1 | POROUS MEMBRANE FOR SECONDARY BATTERY AND SECONDARY BATTERY | ZEON CORPORATION (JP) | 2012-07-26 | — | — | US | disclosed |
| US-8173350-B2 | Oxime compound and resist composition containing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-05-08 | — | — | US | disclosed |
| US-20100028807-A1 | Imide Compound and Chemically Amplified Resist Composition Containing The Same | SUMITOMO CHEMICAL COMPANY, LTD. (JP) | 2010-02-04 | — | — | US | disclosed |
| US-20100021847-A1 | Oxime Compound and Resist Composition Containing the Same | SUMITOMO CHEMICAL COMPANY, LTD. (JP) | 2010-01-28 | — | — | US | disclosed |
| US-7223516-B2 | Positive type photoresist composition | FUJIFILM CORPORATION (JP) | 2007-05-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100028807-A1 | Imide Compound and Chemically Amplified Resist Composition Containing The Same | IGF1R, CCNA1, MYC | TSHR 2519/4885THRB 3151/4885ALDH1A1 386/4885 |
| US-20100021847-A1 | Oxime Compound and Resist Composition Containing the Same | CYC1, UQCRB, CBR1 | TSHR 841/4885THRB 714/4885ALDH1A1 1280/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.